Contact us!     1-877-355-8012  /  [email protected]

Vielight Logo
0

Your cart is currently empty.

Vielight Shop
0

Your cart is currently empty.

Vielight Logo
0

Your cart is currently empty.

Vielight Shop
Access blog archive

Mild Cognitive Impairment (MCI) Clinical Trial Recruitment | University of Toronto | Unity Health Toronto | Vielight Neuro (n=60)

Do you—or someone you love—notice recent memory changes? You may be eligible for a research study at St. Michael’s Hospital in Toronto. This study investigates PBM therapy, a non-invasive method that uses near-infrared (NIR) light—to see whether it can support brain health in people with memory concerns. For more details about this MCI clinical trial: https://clinicaltrials.gov/study/NCT06618807 Why [...]

Alzheimer’s Disease and Brain Photobiomodulation | Clinical Results with Vielight Neuro

This article is based on published independent Alzheimer's research conducted with the Vielight Neuro Gamma by the University of California Vielight Neuro Gamma Read the full Alzheimer's Disease published study with the Vielight Neuro here: Link Introduction Alzheimer's disease (AD) remains one of the most challenging and devastating neurodegenerative conditions affecting millions [...]

Why the nose for brain photobiomodulation?

The nose is a gateway to important brain structures located at the underside of the brain, otherwise, unreachable from the scalp. Can light energy reach the brain from the nose? The layer of skull, just above the nasal cavity and below the brain (the cribriform plate) is extremely porous, delicate and thin. The thin, [...]

MCI and Brain Photobiomodulation | Clinical Results with Vielight Neuro

Mild Cognitive Impairment (MCI) is a condition that often precedes more severe forms of dementia, such as Alzheimer’s disease (AD). A recent clinical study by researchers from the University of Toronto investigated whether a non-invasive technique called transcranial photobiomodulation (tPBM), which uses near-infrared light to stimulate brain cells, could improve brain function in individuals [...]

Research on Microtubulin with Vielight technology | Implications for Alzheimer’s Disease

This new groundbreaking study with Vielight technology conducted in partnership with the Department of Mechanical and Aerospace Engineering University of Turin and the University of Alberta explores the effects of 810nm NIR energy on crucial cellular structures known as tubulin. Healthy cellular function and structure are intrinsically linked to the integrity of tubulins. [...]

Vielight Featured in USA Today!

Vielight featured in USA Today for Alzheimer's and Parkinsons' Research! We were recently featured in USA Today! This independent article covers the modern day challenges that humanity faces and how our Vielight Neuro is being used in cutting-edge photobiomodulation research to study the effects of optimized, high-powered NIR energy delivery to the brain. This [...]

Brain Photobiomodulation: A Potential Drug-Free Option for Alzheimer’s Therapy

Brain Photobiomodulation: A Drug-Free Alternative for Treating Alzheimer's Disease Alzheimer's disease, a progressive neurodegenerative disorder, poses one of the greatest challenges to modern medicine. With its devastating impact on cognitive function and quality of life, finding effective treatments has become an urgent priority. As traditional pharmacological therapies struggle to provide a definitive cure, alternative [...]

40Hz Gamma Neuromodulation in Alzheimer’s Research | Brain Photobiomodulation and Visual Cortex Stimulation

The Ongoing Search for Effective and Accessible Treatments for Alzheimer’s Disease Alzheimer’s disease (AD) is the most common type of dementia in elderly individuals worldwide (Wilson et al., 2012). The disease is characterized by neurodegeneration, tissue changes in the brain, (including amyloid-containing plaques and tangles of hyperphosphorylated tau protein), severe cognitive decline and in [...]

Dementia and Brain Photobiomodulation

In 2015, our dementia pilot trial made history by being the first to show efficacy of brain photobiomodulation (PBM) for dementia in humans with a home-use device, the Vielight Neuro Gamma.[1] In 2019, Dr. Linda Chao, a professor in the Departments of Radiology, Biomedical Imaging and Psychiatry at the University of California, verified our [...]

0